Pharmacokinetics and Safety Profile of Ispronicline (TC1734), a New Brain Nicotinic Receptor Partial Agonist, in Young Healthy Male Volunteers Microsoft Academic Search Recent research suggests that drugs activating nicotine acetylcholine receptors might be promising therapy in cognitive decline seen in the elderly, including Alzheimer???s disease.